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Abstract
Background: Previous studies have focused mainly on the acute effects of smoking on the
diastolic function of the heart. The present study was conducted to demonstrate the chronic
effects of smoking on the diastolic functional parameters of the heart, including transmitral
M- mode coloured flow propagation velocity (Vp), among relatively younger asymptomatic adults.
Method: Hundred smokers with histories of incessant smoking for at least one year prior to the
time of the investigation were included in the prospectively designed study as group I.  Group II
consisted of 35 non-smokers, matched for age and gender. Addiction to smoking was graded
according to the modified Fagerström test for nicotine dependence (M-FNDT). Each smoker
was designated by a nicotine dependence index (NDI) according to the M-FNDT. Groups I
and II were compared with respect to major diastolic functional parameters on transthoracic
echocardiography (TTE), including the E/A ratio, deceleration time (DT), isovolumic relaxa-
tion time (IVRT) and Vp, along with basic clinical and echocardiographic parameters.
Results: Thirty one smokers in group 1 and 5 non-smokers in group 2 were excluded from the study
according to the pre-defined exclusion criteria. Therefore 69 smokers (mean age: 30 – 4.9 years,
M/F: 32/37) in group I were compared with 30 non-smokers (mean age: 31.4 – 4.8 years,
M/F: 15/15) in group II. In group I the mean values of E/A and Vp were significantly lower
(p < 0.001), whereas the mean values of IVRT and DT were significantly higher (p < 0.001)
than in group II. In group I the value of NDI was positively correlated with the values of DT
and IVTR (p < 0.001) and negatively correlated with the value of Vp (p < 0.001).
Conclusion: Conventional and relatively new parameters of cardiac diastolic function, in
particular Vp, were found to be impaired in smokers demonstrating the chronic adverse effects
of smoking on the diastolic function of the heart. The severity of this impairment was closely
correlated with the degree of addiction to smoking. (Cardiol J 2007; 14: 281286)
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Introduction
Diastolic dysfunction is characterised by im-
paired left ventricular (LV) filling and generally
correlates well with ageing [1]. The relaxation proc-
ess is closely associated with active relaxation and
passive chamber stiffness, the latter, in particular,
emerging as more important towards the end of
diastole [2]. Factors interfering with diastolic func-
tion generally interact with one of these two indi-
ces or both. Diastolic dysfunction of the abnormal
relaxation type is particularly due to impairment of
active relaxation and, to a lesser extent, increased
chamber stiffness. Echocardiographic features of
abnormal relaxation are prolongation of isovolumic
relaxation time (IVRT), prolongation of decelera-
tion time (DT), reversal of the E/A ratio, in which
the E wave is normally higher than the A wave, and
reduction in the value of transmitral M-mode col-
oured flow propagation velocity (Vp). Vp is a rela-
tively new parameter typically based on early diasto-
lic intraventricular pressure gradients (IVPG) [3]
between the mitral valve and the apex of the heart.
Vp is therefore considered an efficiency index of
early diastolic filling. In contrast to the conventional
diastolic functional parameters, Vp is, to a large
extent, regarded as a preload-independent index of
diastolic performance [4] and is considered a more
reliable parameter.
Smoking has numerous adverse effects on var-
ious organ systems. Previous studies have focused
particularly on the acute effects of smoking on the
diastolic function of the heart. In the present study
we have tried to investigate the presence of diasto-
lic dysfunction (of abnormal relaxation type) among
relatively young and healthy chronic smokers.
Method
Hundred smokers with histories of incessant
smoking for at least one year prior to the investiga-
tion were included in the prospectively designed study
as group I. The degree of addiction to smoking was
graded according to the modified Fagerström test
for nicotine dependence (M-FNDT) (Table 1) [5].
Each smoker was allocated a nicotine dependence
index (NDI) according to M-FNDT. Group I was
compared with group II, consisting of 35 non-smok-
ers, with respect to major diastolic functional pa-
rameters on transthoracic echocardiography (TTE),
including ratio of E/A, DT, IVRT and Vp. The two
groups were also compared with respect to other
conventional echocardiographic parameters, including
LV end-diastolic diameter (LVEDD), end-diastolic
interventricular septum thickness (EDIVST), end-
diastolic LV posterior wall thickness (EDPWT), left
atrial diameter (LAD) and LV ejection fraction
(LVEF), along with the basic clinical parameters of
heart rate (HR), systolic and diastolic blood pres-
sure (BP) and body mass index (BMI). Heart rate
and blood pressure were measured 10 minutes
prior to echocardiographic examination. Both
smokers and non-smokers were selected from
a group of healthy volunteers of the same ethnic
background.
The presence of the following potential caus-
es of diastolic dysfunction were accepted as exclu-
sion criteria: age > 40, hypertension, infiltrative
diseases, history or evidence of coronary artery
disease and echocardiographic evidence of LV
hypertrophy, systolic dysfunction, wall motion
abnormalities or pericardial disease. In some
instances an abnormal relaxation pattern may be
Table 1. Modified Fagerström test for nicotine dependence.
1. How soon after you wake up do you smoke 4. How many cigarettes do you smoke each day?
your first cigarette? 10 or fewer (0 points)
Within 5 minutes (3 points) 11 to 20 (1 point)
5 to 30 minutes (2 points) 21 to 30 (2 points)
31 to 60 minutes (1 point) 31 or more (3 points)
After 60 minutes (0 points)
2. Do you find it difficult not to smoke in places where 5. Do you smoke more during the first few hours after
you shouldnt, such as in church or school, in a movie, waking up than during the rest of the day?
at the library, on a bus, in court or in a hospital? Yes (1 point)
Yes (1 point) No (0 points)
No (0 points)
3. Which cigarette would you most hate to give up; 6. Do you still smoke if you are so sick that you are in
which cigarette do you treasure the most? bed most of the day, or if you have a cold or the flu
The first one in the morning (1 point) and have trouble breathing?
Any other one (0 points) Yes (1 point)
No (0 points)
Scoring: 7 to 10 points  highly dependent; 4 to 6 points  moderately dependent; fewer than 4 points  minimally dependent.
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complicated by conditions with considerably elevat-
ed LV filling pressures, such as mitral regurgita-
tion or congestive heart failure causing a mitral flow
pattern termed pseudo normalisation with a tall-
er E wave and a shorter A wave [6]. Cases with po-
tential causes of pseudo normalisation were there-
fore excluded from the study. Cases with restric-
tive patterns (a considerably taller E wave with
a reduced A wave), with moderate-to-severe degrees
of valvular regurgitation or stenosis on TTE, cases
with chronic morbidities, including diabetes melli-
tus, bronchial asthma, chronic hepatitis or renal fail-
ure and cases on chronic medication or evidencing
any form of dependence, for example on alcohol,
cocaine or other drugs, were also excluded. Cases
were referred to other departments for diagnosis
where particular conditions were indicated. Smok-
ers and non-smokers were subject to the same ex-
clusion criteria. The exercise stress test was per-
formed in all cases at least 12 hours prior to the TTE
examination. Patients with abnormal initial ECG
(indicating ischaemia or strain, for example), pa-
tients with positive maximal exercise stress tests
(with probable coronary artery disease), and pa-
tients with submaximal tests (those that did not
achieve the target heart rate) were also excluded
from the study.
TTE examination in group I was performed
after an abstinence from smoking ranging between
6 h and 48 h, depending on the compliance of the
smokers, to obviate the acute effects of smoking on
echocardiographic parameters. For the majority of
smokers the abstinence period exceeded 24 h. Only
15 smokers abstained for less than 12 h, the mini-
mum period being 6 h. Echocardiographic exami-
nation was performed by the same single observ-
er, who was not informed of the study design or the
smoking status of the patients.
GE Vingmed Vivid 4 with a 3 MHz transducer
was used for echocardiographic evaluation. The
measurements were performed according to the
proposals of the American Association of Echocar-
diography [7]. In the apical four-chamber pulsed
wave Doppler (PW) was situated at the tips of mi-
tral valves [8] to obtain early (E) and late (A) di-
astolic waves for the calculation of the ratio of E/A
and DT, the interval between the peak and the end
of the E wave, normal value: 179 – 20 ms (< 50 years).
Sample volume was oriented to a position between
the LV outflow tract and mitral valve, where LV
inflow and outflow velocities might be recorded
simultaneously to measure IVRT, the interval be-
tween the end of LV outflow wave and the begin-
ning of early mitral diastolic wave, normal value:
76 – 11 ms (< 50 years). The measurement of Vp
is a relatively new method used in the evaluation
of diastolic function [9]. A coloured M-mode cursor
was situated between the LV inflow tract and apex
to measure Vp in the apical four-chamber view. The
slope of the first red to blue colour transition (the
aliasing velocity) on a plane 4 cm distal in the LV
from the mitral valve plane was accepted as Vp [4],
with values of < 55 cm/s and < 45 cm/s in young
and middle aged adults respectively defining im-
paired relaxation [10]. LVEDD and LAD values
were measured by M-mode in the parasternal long
axis view. The LVEF value was measured by the
modified Simpson method. The mean of the three
consecutively measured values of each parameter
(clinical and echocardiographic) was accepted as the
final value characterising the patient.
Parametric data were expressed as mean –
– standard deviation, and categorical data as per-
centages. SPSS 10.0 was used to perform statisti-
cal procedures. Parametric data were compared by
Students t test and categorical data by the c2 test.
Correlations were searched by Pearsons correla-
tion. A p value £ 0.05 was accepted as significant.
Results
According to the pre-defined exclusion crite-
ria, 31 smokers were excluded from Group I and
5 non-smokers from group II. Therefore 69 smok-
ers (mean age: 30 – 4.9 years, 32 men and 37 wom-
en) in group I were compared with 30 non-smokers
(mean age: 31.4 – 4.8 years, 15 men and 15 wom-
en) in group II. There was no statistically signifi-
cant difference between the two groups with regard
to gender or mean age (p > 0.05). The mean val-
ues of systolic and diastolic BP, HR, BMI, LVEDD,
EDIVST, EDPWT, LAD and LVEF did not differ sig-
nificantly between the two groups either (p > 0.05).
In group I the mean values of Vp, DT and IVRT and
the ratio of E/A were 50.9 – 17 cm/s, 246.6 – 38.4 ms,
140 – 18 ms and 1.1 – 0.12 respectively, while the
same mean values in group II were 110.7 – 38.9 cm/s,
181.1 – 24.9 ms, 98 – 10 ms and 1.37 – 0.1 re-
spectively. In group I the mean values of E/A and
Vp were significantly lower (p < 0.001), whereas the
mean values of IVRT and DT were significantly high-
er (p < 0.001) than those in group II. The mean value
of NDI in group I was found to be 6.01 – 2.44, while
the mean value of smoking duration in group I
was 6.65 – 4.09 years. In group I there were only
9 smokers who had smoked for 1 year while there
were 46 smokers who had smoked for 5 years or
more prior to the investigation. The comparison of
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general features and echocardiographic parameters
between the two groups is shown in Table 2. Table 3
demonstrates a comparison of subgroups in group I
with different NDI values (highly, moderately and
minimally dependent groups classified according to
M-FNDT). Except for the mean value of E/A com-
pared between the moderately and minimally de-
pendent subgroups (p > 0.05), the mean values of
diastolic parameters and NDI differed significantly
between the subgroups, whereas the duration of
smoking did not differ significantly between the
subgroups (p > 0.05).
In group I the value of NDI was positively cor-
related with the values of DT and IVTR (r = 0.73,
r = 0.67 respectively, p<0.001) and negatively cor-
related with the value of Vp (r = 0.90, p < 0.001)
(Fig. 1). The values of NDI and E/A were uncorre-
lated (p > 0.05).
Discussion
Diastolic dysfunction of the heart is generally
defined as increased resistance to diastolic filling of
part or all of the heart. Factors which may impair the
Table 2. Comparison of general and echocardiographic features between smokers and non-smokers.
Group I (smokers) (n = 69) Group II (non-smokers) (n = 30) p value
Mean age [years] 30 – 4.9 31.4 – 4.8 NS 
Gender (M/F) 32/37 15/15 NS
Body mass index [kg/m2] 22.5 – 3.8 23.4 – 4.8 NS
Systolic blood pressure [mm Hg] 122 – 9 115 – 11 NS
Diastolic blood pressure [mm Hg] 75 – 9 73 – 7 NS
Heart rate [beat/min] 72 – 13 68 – 17 NS
LVEDD [cm] 4.4 – 0.5 4.6 – 0.65 NS
EDIVST [mm] 8.10 – 1.60 7.93 – 1.30 NS
EDPWT [mm] 7.80 – 1.95 7.92 – 1.58 NS
Left atrial diameter [cm] 3.7 – 0.6 3.6 – 0.5 NS
Left ventricular ejection fraction [%] 64 – 9 66 – 12 NS
E/A 1.10 – 0.12 1.37 – 0.10 < 0.001
Deceleration time [ms] 246.61 – 38.49 181.14 – 24.9 < 0.001
Isovolumic relaxation time [ms] 140 – 18 98 – 10 < 0.001
Vp [cm/s] 50.90 – 17.07 110.73 – 38.93 < 0.001
Nicotine dependence index 6.01 – 2.44  
Duration of smoking [years] 6.65 – 4.09  
M  male; F  female; LVEDD  left ventricular end-diastolic diameter; EDIVST  end-diastolic interventricular septum thickness; EDPWT  end-
diastolic left ventricular posterior wall thickness; left atrial; E  early diastolic mitral flow rate; A  late diastolic mitral flow rate; Vp  transmitral
M-mode coloured flow propagation velocity; NS  not significant
Table 3. Comparison of the values of diastolic parameters, nicotine dependence index (NDI) and dura-
tion of smoking between subgroups of smokers (highly, moderately and minimally dependent sub-
groups classified according to NDI values).
Group A (NDI = 710) Group B (NDI = 46) Group C (NDI < 4)
Highly dependent Moderately dependent Minimally dependent
(n = 35) (n = 22) (n = 12)
E/A 0.91 – 0.13* 1.25 – 0.7 1.22 – 0.9
Deceleration time [ms] 262.5 – 32.5+, & 238.6 – 12.4** 193.2 – 18.2
Isovolumic relaxation time [ms] 153.6 – 14.5+, & 137.5 – 12.5** 109.2 – 21.5
Vp [cm/s] 39.5 – 8.5+, & 54.4 – 6.5** 84.5 – 11.95
Nicotine dependence index 8.20 – 1.10# 5.04 – 0.65& 1.9 – 0.79
Duration of smoking [years] 6.83 – 4.95 6.68 – 3.98 6.50 – 3.94
E  early diastolic mitral flow rate; A  late diastolic mitral flow rate; Vp  transmitral M-mode coloured flow propagation velocity; *p < 0.05 vs.
group B and group C; +p < 0.05 vs. group B; &p < 0.001 vs. group C; #p < 0.001 vs. group B and group C; **p < 0.05 vs. group C
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diastolic function of the heart include coronary artery
disease [11], infiltrative cardiac diseases such as amy-
loidosis, LV hypertrophy and pericardial diseases [12].
Smoking has numerous adverse effects on var-
ious organ systems, but the most adversely affect-
ed ones are the respiratory and circulatory systems.
In addition to other well-documented harmful
effects, smoking has been reported to have adverse
effects on the diastolic function of the heart. Previ-
ous studies have mainly focused on the acute
effects of smoking on diastolic function in different
groups. Alam et al. [13] reported acute adverse effects
of smoking on diastolic function by using convention-
al and mitral annular Doppler parameters in a group
of 36 healthy participants. Kyriakides et al. [14] in-
vestigated the acute effects of smoking a single cig-
arette on diastolic function in a group of 20 patients
with angiographically documented coronary artery
disease by using conventional parameters and re-
ported no prolongation of IVRT and DT values but
a decrease in the ratio of E/A compared with the
control group. Similarly, Stork et al. [15] reported
acute adverse effects of smoking a single cigarette
on diastolic function by using conventional param-
eters in a group of 28 smokers with documented
coronary artery disease.
The present study also demonstrated the ad-
verse effects of smoking on diastolic function of the
heart, but the major difference from the above-
mentioned studies was the demonstration of the
chronic adverse effects of smoking on diastolic func-
tion by using both conventional parameters and Vp
in a larger population of relatively younger healthy
smokers. Both conventional parameters and Vp,
which is more reliable and preload-independent,
worked well in demonstrating the chronic adverse
effects of smoking on diastolic function.
There are possible explanations for the chron-
ic adverse effects of smoking on the diastolic func-
tion of the heart, as demonstrated in the present
study. Smoking has long been known to impair the
structure of connective tissue in various organ sys-
tems. Increased arterial stiffness in smokers has
been linked to structural alterations in the vascular
media, including calcification [16], increased colla-
gen and reduced elastin content [17]. Regardless
of the presence of atherosclerosis, arterial and
myocardial stiffness have been clinically important
in smokers. In canine models exposed to nicotine,
increased LV chamber stiffness was reported to be
due to increased collagen deposition and collagen
cross-links in the myocardium [18]. Fibrotic chang-
es throughout the myocardium due to collagen dep-
osition may impair diastolic function in smokers.
Impaired regulation of nitric oxide (NO) syn-
thesis in the myocardium may be another possible
mechanism explaining the impairment of relaxation
in smokers. NO is synthesised via nitric oxide syn-
thase (NOS). There are three known isoforms of
NOS (NOS1, NOS2 and NOS3). Of these, NOS2 and
NOS3 are known to be expressed in the human
myocardium. NOS2 is an inducible isoform and is
not normally expressed, whereas NOS3 is endothe-
lial and is physiologically expressed in the normal
myocardium. The amount of NO synthesised via
NO3 is generally much lower. The lower physio-
logical amount of NO has some beneficial effects,
including an improvement in remodelling after
myocardial infarction [19] and amelioration of ven-
tricular relaxation (lusiotrophy). Smoking is a well-
known factor that induces endothelial dysfunction
through impairment of NO production [20, 21].
Smoking may also impair ventricular relaxation by
inhibiting physiological expression of NO3 in the
myocardium.
There may be clinical outcomes of asympto-
matic diastolic dysfunction. The presence of diasto-
lic dysfunction in an asymptomatic patient has been
reported as a risk factor for the future development
of heart failure [22]. In other terms, asymptomatic
diastolic dysfunction may be an early marker of an
increased risk of symptomatic heart failure and
subsequent mortality. Patients with diastolic dys-
function are also considered to be susceptible to
ventricular arrhythmias [23] and sudden cardiac
death. An increased risk of arrhythmogenesis in
Figure 1. The negative correlation between the nicotine
dependence index (NDI) and transmitral M-mode colo-
ured flow propagation velocity (Vp).
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diastolic dysfunction may be due to myocardial
fibrosis, increased sympathetic tone, changes in ex-
citation-contraction coupling [23] and also to the
minimal pathological changes in coronary microcir-
culation that do not induce documentable ischaemic
changes [24]. In the present study these outcomes
were not documented owing to the study design,
but in long-term clinical follow-up smokers with
asymptomatic diastolic dysfunction may be at in-
creased risk for these outcomes.
In conclusion, the diastolic function of the heart
was found to be impaired among relatively young-
er healthy smokers. The severity of this impairment
was closely correlated with the degree of addiction
to smoking. Further large-scale studies are required
to confirm the present study. Healthy smokers with
asymptomatic diastolic dysfunction may be at in-
creased risk for future morbidities in long-term clin-
ical follow-up. Long-term prospective studies based
on follow-up of these patients are also warranted
in order to clarify this issue.
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